Accessibility Menu
Columbus Circle Capital II logo

Columbus Circle Capital II(NASDAQ) CMII

Market Cap$313.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)+2%
5 YearN/A
1 YearN/A
1 Month-1%
$10.02
+0.00%
+0.00Today
After hours$10.03+$0.01 (+0.05%)
Columbus Circle Capital II last closing stock price
MetricPriceDate
Last closeUSD 10.022026-08-10
Columbus Circle Capital II stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.1%USD 10.012026-08-03
1 month-1.09%USD 10.132026-07-10
3 month+1.17%USD 9.902026-05-12
Since inception+2.14%USD 9.812026-02-27

Columbus Circle Capital II Financials at a Glance

Market Cap

$313.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$0.82

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.58 (Low)

Price

$10.02

Volume

42,088

Open

$10.03

Previous Close

$10.02

Daily Range

$10.01 - $10.03

52-Week Range

$9.76 - $10.22

Estimated Earnings Date

N/A

CMII News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Columbus Circle Capital II

CM Life Sciences II helps private companies become public through mergers. It offers a financial vehicle, not products, for businesses seeking U.S. market access. Its main role is connecting capital with companies in life sciences and other sectors.

What’s in the Toolbox? (Products and Services)

  • SPAC Vehicle: Provides a public listing route for private companies; 100% of revenue (no other products).
  • Capital Access: Offers funding to companies seeking to enter U.S. public markets.
  • Business Combination Platform: Facilitates mergers, stock exchanges, or asset acquisitions for target firms.
  • Network Leverage: Connects with private companies, financial sponsors, and investment banks for deal sourcing.
  • PIPE Financing: Arranges private investment in public equity for transaction support.

Growth and Expansion: The Road So Far

  • Incorporated in 2020, targeting the life sciences sector.
  • Completed IPO in February 2026, raising $230 million for future deals.
  • Sold 665,000 private placement units to the Sponsor and the Representatives in February 2026.
  • Focuses on companies in EMEA and LatAm regions seeking U.S. market entry.
  • No business combinations or acquisitions completed as of December 2025.

What Makes CM Life Sciences II Stand Out?

CM Life Sciences II operates globally, targeting companies in Europe, the Middle East, Africa, and Latin America. Its management team brings experience in mergers and capital markets, using a broad network to find deals. The company’s structure allows it to quickly deploy capital to private firms seeking U.S. listings.

Five Things You Need to Know

  • No operating revenue as of December 31, 2025.
  • Net loss of $46,064 for April–December 2025, all administrative costs.
  • IPO raised $230 million in February 2026 for future acquisitions.
  • All IPO proceeds placed in a trust account for business combinations.
  • Faces a 24-month deadline to complete a deal or liquidate.

Bottom Line

CM Life Sciences II is a blank check company designed to merge with private firms. Its evolution depends on finding and completing a business combination within two years.

AI Generated • Apr 16, 2026

Industry

Capital Markets

Sector

Financials

Employees

2

CEO

Gary Quin, MBA

Headquarters

New York, NY 10019, US

CMII Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$313.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

31.33M

Volume

42.09K

Avg. Volume

144.84K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Columbus Circle Capital II Performance Analysis

Columbus Circle Capital II annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20252025-12-31USD 0N/A
Columbus Circle Capital II annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20252025-12-31USD -0.00N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

N/A

N/A

Market Cap

$313.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$98.30

N/A

Employees

2

N/A

Net Income

$0.85

N/A

EBITDA

-$0.20

N/A

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.19

N/A

Total Debt

$0.00

N/A

Accounts Receivable

N/A

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

218.69%

N/A

Free Cash Flow

-$0.29

N/A

Operating Cash Flow

-$0.29

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,747.67-0.00%
^DJIDJI
$53,859.14-0.00%
^IXICNASDAQ
$26,571.33-0.00%
BTCBitcoin
$63,877.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$73.80-0.01%
INTCIntel
$97.52-0.04%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.73+0.01%
SPCXSpace Exploration Technologies
$138.74+0.04%

Questions About CMII

What is the current price of Columbus Circle Capital II?

Columbus Circle Capital II is trading at $10.02 per share.

What is the 52-week range for Columbus Circle Capital II?

Over the past 52 weeks, Columbus Circle Capital II has traded between $9.76 and $10.22.

How much debt does Columbus Circle Capital II have?

As of the most recent reporting period, Columbus Circle Capital II reported total debt of $0.00.

How much cash does Columbus Circle Capital II have on hand?

Columbus Circle Capital II reported $1.19M in cash and cash equivalents in its most recent financial results.

What is Columbus Circle Capital II’s dividend yield?

Columbus Circle Capital II does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services